Form 4: Bio-Key International Director Cameron E. Williams Reports Stock Acquisitions

Cameron E. Williams, a director at Bio-Key International, reported acquiring shares of common stock through restricted stock grants and board committee meeting attendance fees.

Summary

• On July 31, 2024, Cameron E. Williams, a director of Bio-Key International, acquired 3,500 shares of common stock as restricted stock under the company's 2023 Stock Incentive Plan.
• These shares vest in three equal annual installments, contingent upon continued service to the Issuer.
• Additionally, Williams acquired 676 shares of common stock on the same date as payment for board committee meeting attendance fees.
• Following these transactions, Williams beneficially owns 6,229 shares of Bio-Key International common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a director. The acquisition of shares can be seen as a positive sign, but it's not a major event.

Positives

• The director's acquisition of shares, particularly restricted stock, signals confidence in the company's future performance.
• The use of stock to compensate board members aligns their interests with those of shareholders.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The disclosure provides transparency to shareholders regarding insider transactions.
• The stock grants to the director align his interests with those of the shareholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Incentive Plan, Restricted Stock, Director, BKYI, Bio-Key International, Cameron E. Williams